So when he found himself examining protein mutations that cause cardiac arrhythmias in a laboratory at the University of British Columbia’s Department of Biochemistry and Molecular Biology, he knew he’d come a long way from where he once was.
The appearance of multidrug resistance of pathogens is challenging the researcher and industrial communities to develop more efficacious antimicrobial treatments. Blue-O Technology Incorporation (Blue-O Tech) has developed a novel formulation of medicine that accelerates the wound healing, while having an excellent antimicrobial strength over a broad spectrum of pathogens. The objectives of this study are to evaluate the cytotoxic effects, the immunological response, and the healing properties of this novel medicine prior to its marketing and commercialization.
Aarya— a third-year biotechnology student— was hoping to be able to hone her laboratory skills and knowledge of life sciences research before completing the final year of her degree. Though she had applied to a highly competitive life sciences research term in New York and was accepted to the prestigious Indian Academy of Sciences research program, Aarya chose to accept an internship with the Mitacs Globalink program because of the chance to take part in cancer research at the University of British Columbia under Dr. Christian Naus in the Department of Cell and Physiological Sciences.
Having completed an internship in South Korea last year, where he developed a wireless camera surveillance system for police vehicles, the bright Electronics and Communications Engineering student turned down an internship at Massachusetts Institute of Technology to come to University of British Columbia Vancouver through Mitacs Globalink.
Every year, thousands of Canadian children are diagnosed with, or treated for, brain disorders such as Fetal Alcohol Spectrum Disorders (FASD), Autism Spectrum Disorders (ASD) and cerebral palsy. As a national scientific research network, NeuroDevNet has dedicated its mission towards finding the root causes of these disorders.
Given the plurality of voices available on the Internet, it is often difficult to estimate the level of expertise of the individuals that one encounters in cyber-space. On the other hand, it is also difficult for any individual expert to establish their credibility in this sea of screaming voices. Therefore, it is desirable to have an independent mechanism to prove a given person's claims to authenticity and legitimacy. One valuable source of information in this endeavour is the individual's interactions with content on the web, be it blogging, tweeting, etc.
The Honna River is a source of drinking water for the Village of Queen Charlotte on Haida Gwaii, British Columbia. There is concern that sediment from a highly traveled logging road is contributing to poor water quality in the Honna River. This project is following up on the work of Elizabeth Baird (2010 Mitacs Intern), where she determined what factors controlled sediment leaving logging roads. However, the dataset she used was limited to a 10 month period. This project has two main objectives using a longer dataset collected over the past 3 years: 1.
After completing his Bachelors and Masters degrees in Tehran, then working at a car manufacturing company, the loss of a close family member to cancer changed his goals for the future. He set his sights on biotechnology at the University of British Columbia. Ahmadi initially thought this meant a career destined for academia, but since attending eight Mitacs Step workshops he says “My eyes were opened to the opportunities outside of academia and I started to think about my career differently.”
Over the years, the methodology for public consultation has evolved to include public information meetings and hearings, telephone polls and surveys, and most recently online engagement. Increasingly, government is emphasizing evidence-based decision-making. They recognize that existing methods are lacking in reaching a broad demographic. Internet communication technology has made it possible to reach a broader spectrum of the public. However, until recently, that interaction has been anonymous and anecdotal at best.
Glioblastoma (GBM) is the most common and aggressive form of brain cancers and is the second most common cancer in children only behind leukemia. Conventional therapy consists primarily of surgery, radiation, and chemotherapy, and while these approaches have slightly improved the length of patient survival, there remains no cure for this disease. With the emerging understanding of biology in the process of cancer development, identification of therapeutic targets are being elucidated that will allow more targeted and effective treatment of the disease.